2
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Genitourinary
1
Conditions
Leukemia, Myeloid, Acute
561
Leukemia
282
Precursor Cell Lymphoblastic Leukemia-Lymphoma
235
Lymphoma
160
Myelodysplastic Syndromes
111
Burkitt Lymphoma
91
Congenital Abnormalities
86
Lymphoma, Non-Hodgkin
85
Leukemia, Monocytic, Acute
84
Leukemia, Myelomonocytic, Acute
82
Lymphoma, Large B-Cell, Diffuse
80
Leukemia, Erythroblastic, Acute
75
Leukemia, Megakaryoblastic, Acute
72
Recurrence
70
Lymphoma, Mantle-Cell
70
Lymphoma, Follicular
49
Hodgkin Disease
44
Leukemia, Myelomonocytic, Chronic
43
Leukemia, Biphenotypic, Acute
43
Lymphoma, Large-Cell, Immunoblastic
37
Blast Crisis
37
Anemia, Refractory, with Excess of Blasts
36
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
35
Leukemia, Lymphocytic, Chronic, B-Cell
33
Myeloproliferative Disorders
30
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
28
Lymphoma, B-Cell, Marginal Zone
24
Leukemia, Myeloid, Chronic-Phase
23
Leukemia, Eosinophilic, Acute
23
Leukemia, Basophilic, Acute
22
Interventions
Docetaxel
292
Prednisone
241
enzalutamide
195
Leuprolide
185
Radiotherapy
179
Abiraterone Acetate
170
Magnetic Resonance Spectroscopy
163
bicalutamide
141
Goserelin
138
Androgen Antagonists
121
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
108
Radiosurgery
108
apalutamide
93
abiraterone
83
gallium 68 PSMA-11
81
Specimen Handling
73
darolutamide
67
Surveys and Questionnaires
64
Gonadotropin-Releasing Hormone
63
Triptorelin Pamoate
58
Radiation
57
Biopsy
57
Brachytherapy
54
cabazitaxel
53
Standard of Care
51
Radiotherapy, Intensity-Modulated
51
Zoledronic Acid
50
pembrolizumab
49
luprolide acetate gel depot
49
Flutamide
47
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Prostatic Neoplasms
×
Cytarabine
×
Clear all
NCT00480090
2019-02-15
SLAP
University Health Network, Toronto
Phase 2
Completed
10 enrolled